Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

23.99 -1.94 (-7.48%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2026 Add to My Watchlist

Price and Volume

Volume	2,478,120
Open	25.40
Bid (Size)	23.75 (200)
Ask (Size)	23.98 (100)
Prev. Close	25.93
Today's Range	23.80 - 25.60
52wk Range	16.24 - 45.30
Shares Outstanding	308,456,852
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Legend Biotech Stock Crushed the Market on Monday ↗

April 20, 2026

Two analysts weighed in positively about the company's future.

Via The Motley Fool

Legend Biotech (LEGN) Q4 2025 Earnings Transcript ↗

April 01, 2026

Legend Biotech (LEGN) Q4 2025 Earnings Transcript

Via The Motley Fool

Performance

YTD	+11.5%	+11.5%
1 Month	+40.4%	+40.4%
3 Month	+24.0%	+24.0%
6 Month	-24.3%	-24.3%
1 Year	-30.1%	-30.1%

More News

Legend Biotech (LEGN) Q2 2025 Earnings Transcript ↗

April 01, 2026

Via The Motley Fool

Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q4 2025 Results, Beats on EPS ↗

March 10, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

What to Expect from Legend Biotech's Earnings ↗

November 11, 2025

Via Benzinga

Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗

April 01, 2026

Via The Motley Fool

Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗

April 01, 2026

Via The Motley Fool

This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗

March 19, 2026

Via The Motley Fool

Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

March 10, 2026

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results

February 24, 2026

From Legend Biotech USA Inc.

Via GlobeNewswire

These stocks are gapping in today's session ↗

February 23, 2026

Via Chartmill

These stocks are moving in today's pre-market session ↗

February 23, 2026

Via Chartmill

HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model ↗

February 20, 2026

Via The Motley Fool

Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use

January 21, 2026

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026

From Legend Biotech USA Inc.

Via GlobeNewswire

Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗

December 23, 2025

Via The Motley Fool

Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗

December 23, 2025

Via The Motley Fool

Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 17, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

December 06, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

November 13, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights

November 12, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

November 03, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Inside the Fintech Platform Winning Over a New Generation of Investors in Asia ↗

October 31, 2025

Via The Motley Fool

XP’s New Backer Sees Opportunity in Brazil’s Next Financial Chapter ↗

October 30, 2025

Via The Motley Fool

Frequently Asked Questions

Is Legend Biotech Corporation - American Depositary Shares publicly traded?

Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.

What exchange does Legend Biotech Corporation - American Depositary Shares trade on?

Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?

The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market

What is the current price of Legend Biotech Corporation - American Depositary Shares?

The current price of Legend Biotech Corporation - American Depositary Shares is 23.99

When was Legend Biotech Corporation - American Depositary Shares last traded?

The last trade of Legend Biotech Corporation - American Depositary Shares was at 04/23/26 04:00 PM ET

What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?

The market capitalization of Legend Biotech Corporation - American Depositary Shares is 7.40B

How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?

Legend Biotech Corporation - American Depositary Shares has 7B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.